Prüfung der Wirksamkeit und Verträglichkeit von "Organ-Serum Prostata" bei Patienten mit benigner Prostatahyperplasie. Ergebnisse einer randomisierten, multizentrischen Doppelblind-Studie

Author(s): Babej-Dölle, R., Heidl, R., Kastner, H. -G., Schneider, H. -J.

Journal/Book: extracta urologica. 1989; 12: 392-396.

Abstract: A double-blind, randomized, multicentric study was carried out to test efficacy and tolerance of Â„Organ-Serum Prostata" in patients with benign prostatic hyperplasia.The patients were observed for 24 weeks. Micturition difficulties were reduced.14 weeks after the end of the therapy significantly fewer people in the verumgroup suffered from discontinuous evacuation of the urinary bladder.The sonographic examination findings and the findings per rectum did not change. The maximum volume per second increased by 7,7 ml/sec. in group I (verum) und by 5,0 ml/sec. in group II (Lachemistol).The micturition volume increased until 8 weeks after the end of the therapy and decreased afterwards. In group I the time was reduced by 12,1 seconds, in group II by 1,8 seconds. The amount of remaining urine decreased by 24,3 ml (group I) respectively 12,7 ml (group II). The safety laboratory values were unobtrusive.Side effects were mainly observed as redness, itching and swelling of lymphnodes in 7 out of 27 patients in group I and 9 out of 22 patients in group 11. They did not cause any drop-out.20 weeks after the end of therapy the physicians judged the efficacy of Â„Organ-Serum Prostata" to be significantly better than Lachemistol. As expected the tolerance of Lachemistol was better.The results demonstrate the efficacy and tolerance of Â„Organ-Serum Prostata" in the therapy of patients with benign prostatic hyperplasia.

Zurück | Weiter